修改黄类药物的生物制药参数:一篇综述
Amir Taldaev1,2,3, Artem A Svotin4, Semyon I Obukhov4
1Laboratory for the Study of Single Biomacromolecules, Institute of Biomedical Chemistry, Moscow, Russia.
Frontiers in chemistry
|May 14, 2025
概括
这项研究系统化了增强黄胺溶解度和生物可用性的方法. 包容复合物和纳米结构显著提高了药物动力学参数,有助于药物开发.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 药物输送系统 药物输送系统
背景情况:
- 黄类,天然的多类,具有多样化的生物效应,但其生物可用性较低,阻碍了药物开发.
- 现有的改善黄酸可溶性和生物利用性的策略是分散的,需要一个整合的概述.
- 本综述探讨了关于在不改变分子结构的情况下增强黄类生物可用性的系统化数据的需求.
研究的目的:
- 整合和系统化关于增加黄酸可溶性和生物可用性的方法的科学数据.
- 为了比较不同增强策略在药理动力学参数上的疗效.
- 确定最有效的方法来改善药物开发中的黄类生物可用性.
主要方法:
- 系统审查和数据整合的研究,关于黄胺溶解度和生物可用性增强.
- 分析方法包括共结晶,脂复合物,包容复合物和纳米结构.
- 评估药物动力学参数,如曲线下的面积,半衰期和最大度.
主要成果:
- 包括复合物和纳米结构在药物动力学曲线下的面积 (分别为4.2x和3.7x) 增加最大.
- 脂复合体导致平均消除半衰期增加2.1倍.
- 纳米结构和细胞显著增加了血中的最大度,平均是5.4倍.
- 研究中的溶解性评估方法的异质性使直接比较变得复杂.
结论:
- 同结晶,脂复合体,包容复合体和纳米结构是提高黄类生物可用性的关键策略.
- 包括复合物和纳米结构在药物动力学参数中提供了最显著的改进.
- 这些发现为选择最佳方法提供了关键的指导,以根据所期望的结果改善黄类生物可用性.
相关概念视频
Drug Biotransformation: Overview
2.2K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.2K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
156
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
156
Factors Affecting Drug Biotransformation: Biological
83
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
83
Factors Influencing Drug Absorption: Pharmaceutical Parameters
104
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
104
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
135
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
135
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
50
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
50


